These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

198 related items for PubMed ID: 14726416

  • 1. Constitutive expression and involvement of cyclooxygenase-2 in human megakaryocytopoiesis.
    Tanaka N, Sato T, Fujita H, Morita I.
    Arterioscler Thromb Vasc Biol; 2004 Mar; 24(3):607-12. PubMed ID: 14726416
    [Abstract] [Full Text] [Related]

  • 2. Cyclooxygenase-2 expression is induced during human megakaryopoiesis and characterizes newly formed platelets.
    Rocca B, Secchiero P, Ciabattoni G, Ranelletti FO, Catani L, Guidotti L, Melloni E, Maggiano N, Zauli G, Patrono C.
    Proc Natl Acad Sci U S A; 2002 May 28; 99(11):7634-9. PubMed ID: 12032335
    [Abstract] [Full Text] [Related]

  • 3. Regulation of bone morphogenetic protein-2 expression by endogenous prostaglandin E2 in human mesenchymal stem cells.
    Arikawa T, Omura K, Morita I.
    J Cell Physiol; 2004 Sep 28; 200(3):400-6. PubMed ID: 15254968
    [Abstract] [Full Text] [Related]

  • 4.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 5. Induction of cyclooxygenase-1 in cultured synovial cells isolated from rheumatoid arthritis patients.
    Onodera M, Horiuchi Y, Nakahama K, Muneta T, Mano Y, Morita I.
    Inflamm Res; 2004 Jun 28; 53(6):217-22. PubMed ID: 15167967
    [Abstract] [Full Text] [Related]

  • 6. COX-2 is not involved in thromboxane biosynthesis by activated human platelets.
    Patrignani P, Sciulli MG, Manarini S, Santini G, Cerletti C, Evangelista V.
    J Physiol Pharmacol; 1999 Dec 28; 50(4):661-7. PubMed ID: 10639016
    [Abstract] [Full Text] [Related]

  • 7.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 8. Long-term platelet production assessed in NOD/SCID mice injected with cord blood CD34+ cells, thrombopoietin-amplified in clinical grade serum-free culture.
    Mattia G, Milazzo L, Vulcano F, Pascuccio M, Macioce G, Hassan HJ, Giampaolo A.
    Exp Hematol; 2008 Feb 28; 36(2):244-52. PubMed ID: 18023520
    [Abstract] [Full Text] [Related]

  • 9. [Effects of selective cyclooxygenase-2 inhibitor NS-398 on 5-fluorouracil chemotherapy and progression of colon cells: an experimental study].
    Zhang YC, Wang S, Zhang H, Ye YJ, Liang B, Cui ZR.
    Zhonghua Yi Xue Za Zhi; 2004 Apr 02; 84(7):583-6. PubMed ID: 15144595
    [Abstract] [Full Text] [Related]

  • 10. Suppressive effect of selective cyclooxygenase-2 inhibitor on cytokine release in human neutrophils.
    Kimura T, Iwase M, Kondo G, Watanabe H, Ohashi M, Ito D, Nagumo M.
    Int Immunopharmacol; 2003 Oct 02; 3(10-11):1519-28. PubMed ID: 12946449
    [Abstract] [Full Text] [Related]

  • 11.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 12. Involvement of cyclooxygenase-2 in rat models of conjunctivitis.
    Oka T, Shearer T, Azuma M.
    Curr Eye Res; 2004 Jul 02; 29(1):27-34. PubMed ID: 15370364
    [Abstract] [Full Text] [Related]

  • 13. Cyclooxygenase-2 inhibitor treatment enhances photodynamic therapy-mediated tumor response.
    Ferrario A, Von Tiehl K, Wong S, Luna M, Gomer CJ.
    Cancer Res; 2002 Jul 15; 62(14):3956-61. PubMed ID: 12124326
    [Abstract] [Full Text] [Related]

  • 14. Cyclooxygenase isoforms and platelet vessel wall interactions in the apolipoprotein E knockout mouse model of atherosclerosis.
    Belton OA, Duffy A, Toomey S, Fitzgerald DJ.
    Circulation; 2003 Dec 16; 108(24):3017-23. PubMed ID: 14638539
    [Abstract] [Full Text] [Related]

  • 15.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 16. Regeneration of megakaryocytopoiesis and thrombopoiesis in vitro from X-irradiated human hematopoietic stem cells.
    Kashiwakura I, Inanami O, Abe Y, Satoh K, Takahashi TA, Kuwabara M.
    Radiat Res; 2006 Aug 16; 166(2):345-51. PubMed ID: 16881735
    [Abstract] [Full Text] [Related]

  • 17. The COX-2 inhibitor NS-398 causes T-cell developmental disruptions independent of COX-2 enzyme inhibition.
    Xu H, Izon DJ, Loftin C, Spain LM.
    Cell Immunol; 2001 Dec 15; 214(2):184-93. PubMed ID: 12088417
    [Abstract] [Full Text] [Related]

  • 18. Selective COX-2 inhibitor, NS-398, inhibits the replicative senescence of cultured dermal fibroblasts.
    Han JH, Roh MS, Park CH, Park KC, Cho KH, Kim KH, Eun HC, Chung JH.
    Mech Ageing Dev; 2004 May 15; 125(5):359-66. PubMed ID: 15130753
    [Abstract] [Full Text] [Related]

  • 19.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 20. Expression of cyclooxygenase-2 (COX-2) in human esophageal cancer and in vitro inhibition by a specific COX-2 inhibitor, NS-398.
    Yu HP, Shi LY, Lu WH, Su YH, Li YY, Xu SQ.
    J Gastroenterol Hepatol; 2004 Jun 15; 19(6):638-42. PubMed ID: 15151617
    [Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 10.